Despite an initial FIGO IVB classification and high tumor burden, she achieved prolonged remission, highlighting the known impact of optimal cytoreductive surgery, platinum sensitivity, BRCA2 mutation status, and anti-VEGF therapy. This evidence concerns the gene BRCA2 and neoplasm.